[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"urologic-injuries\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:urologic-injuries":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":4},"100650225","phase-4-the-clinical-research-of-traditional-chinese-medicine-formula-100650225",false,"NCT07746219","The Clinical Research of Traditional Chinese Medicine Formula","A Clinical Study on Bushen Huoxue Simiao Formula for Nourishing the Kidneys and Promoting Blood Circulation to Improve Postoperative Complications of Upper Urinary Tract Stones","Inclusion Criteria:\n\n1. Meet the Western medicine diagnostic criteria: Patients who need lithotripsy surgery and have a double J stent (4.7F, 28 cm) placed after surgery; plain film of kidney and upper bladder indicates normal position of ureteral stent and no need for stage II surgery.\n2. Meet the Traditional Chinese Medicine (TCM) diagnostic criteria.\n3. Aged between 18 and 80 years old (inclusive).\n4. Voluntary participation with signed informed consent.\n\nExclusion Criteria:\n\n1. Patients with renal insufficiency stage 4 or 5, or acute renal failure.\n2. Secondary factors confirmed by examination, such as systemic lupus erythematosus or drug-induced kidney damage.\n3. Does not meet the diagnosis of upper urinary tract stones.\n4. Cases not within the scope of drug action.\n5. Long-term use of other relevant therapeutic drugs, or inability to stop medication immediately.\n6. Late-stage deformity, disability, or loss of labor ability.\n7. Complicated with severe primary diseases of heart, brain, liver, hematopoietic system, endocrine system, etc., or mental illness.\n8. Pregnant or lactating women.\n9. Patients in critical condition.\n10. Other conditions deemed unsuitable for enrollment by the researchers.","ALL","18 Years","80 Years",{"count":20,"type":21},80,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","This study examines the efficacy and safety of Bushen Huoxue Simiao formula for tonifying the kidneys and promoting blood circulation in treating postoperative complications of upper urinary tract stones, thereby providing evidence-based medical evidence and treatment strategies for clinical practice.",[27,28],"Urologic Injuries","Kidney Disease",[30,31,32],"Traditional Chinese Medicine","Renal Fibrosis","Renal Stone","NOT_YET_RECRUITING","2026-07-30",{"date":36,"type":37},"2026-08-04","ACTUAL",{"date":39,"type":21},"2026-08-31",{"date":41,"type":21},"2028-08-31",{"name":43,"class":44},"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","OTHER",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},"100604762","phase-4-the-clinical-research-of-traditional-chinese-medicine-compound-formulas-100604762","NCT07153731","The Clinical Research of Traditional Chinese Medicine Compound Formulas","Observation on the Clinical Efficacy of Shenkangling in the Treatment of Renal Ischemia-reperfusion Injury (Kidney Deficiency and Blood Stasis Syndrome)","Inclusion Criteria:\n\n1. Fulfillment of western medical diagnostic criteria requiring renal ischemia-reperfusion surgical operation and renal artery clamping time ≤ 30 min\n2. Meets the criteria for Chinese medicine identification\n3. 18 ≤ age ≤ 65\n4. Voluntary participation with signed informed consent\n\nExclusion Criteria:\n\n1. Patients with stage 4 or 5 renal insufficiency or patients with acute renal failure\n2. Those with secondary factors such as systemic lupus erythematosus, drug-induced renal damage, etc. confirmed by examination\n3. Does not meet the diagnosis of renal ischemia-reperfusion injury\n4. Cases not within the scope of action of the drug\n5. Those who have been taking other related therapeutic drugs for a long period of time, e.g., taking Chinese medicines such as Jingui Shenqi Pills by mouth for a long period of time, or those who are unable to stop taking the medicines immediately.\n6. Advanced deformity, disability, loss of labor force\n7. Combined heart, brain, liver, hematopoietic system, endocrine system and other serious primary diseases and psychiatric patients\n8. Pregnant or lactating women\n9. Critically ill patients\n10. Other circumstances deemed inappropriate for inclusion in the study","65 Years",{"count":54,"type":21},100,[24],"To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.",[27,58],"Urology",[30,31,60],"Renal Ischemia-reperfusion Injury","2025-09-03",{"date":63,"type":37},"2025-09-04",{"date":65,"type":21},"2025-10-01",{"date":67,"type":21},"2027-07-01",{"name":43,"class":44},1]